NO961274D0 - Azolderivat og farmasöytiske preparat derav - Google Patents

Azolderivat og farmasöytiske preparat derav

Info

Publication number
NO961274D0
NO961274D0 NO961274A NO961274A NO961274D0 NO 961274 D0 NO961274 D0 NO 961274D0 NO 961274 A NO961274 A NO 961274A NO 961274 A NO961274 A NO 961274A NO 961274 D0 NO961274 D0 NO 961274D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
azole derivatives
azole
derivatives
preparations
Prior art date
Application number
NO961274A
Other languages
English (en)
Other versions
NO961274L (no
Inventor
Minoru Okada
Toru Yoden
Eiji Kawaminami
Yoshiaki Shimada
Tsukasa Ishihara
Masafumi Kudou
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO961274D0 publication Critical patent/NO961274D0/no
Publication of NO961274L publication Critical patent/NO961274L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961274A 1993-09-30 1996-03-29 Azolderivat og farmasöytiske preparat derav NO961274L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24494493 1993-09-30
PCT/JP1994/001593 WO1995009157A1 (fr) 1993-09-30 1994-09-28 Derive d'azole et composition pharmaceutique le contenant

Publications (2)

Publication Number Publication Date
NO961274D0 true NO961274D0 (no) 1996-03-29
NO961274L NO961274L (no) 1996-03-29

Family

ID=17126291

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961274A NO961274L (no) 1993-09-30 1996-03-29 Azolderivat og farmasöytiske preparat derav

Country Status (12)

Country Link
US (1) US5807880A (no)
EP (1) EP0721943A4 (no)
KR (1) KR960704852A (no)
CN (1) CN1131944A (no)
AU (1) AU679119B2 (no)
CA (1) CA2170874A1 (no)
FI (1) FI961418A (no)
HU (1) HUT75871A (no)
NO (1) NO961274L (no)
NZ (1) NZ273681A (no)
PL (1) PL313769A1 (no)
WO (1) WO1995009157A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934941A1 (en) 1996-08-09 1999-08-11 Eisai Co., Ltd. Benzopiperidine derivatives
US6420375B1 (en) 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
US6559157B2 (en) 1997-10-02 2003-05-06 Daiichi Pharmaceutical Co., Ltd. Dihydronaphthalene compounds
IL133483A0 (en) * 1997-10-02 2001-04-30 Yukijirushi Nyugyo Kabushiki K Novel dihydronaphthalene compounds and processes of producing the same
JP4546589B2 (ja) * 1998-04-23 2010-09-15 武田薬品工業株式会社 ナフタレン誘導体
US6573289B1 (en) 1998-04-23 2003-06-03 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
JP4520012B2 (ja) * 1999-10-22 2010-08-04 武田薬品工業株式会社 1−置換−1−(1h−イミダゾール−4−イル)メタノール類
US6518257B1 (en) 1999-10-22 2003-02-11 Takeda Chemical Industries, Ltd. 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
AU2002214296C1 (en) 2000-11-17 2006-04-13 Takeda Pharmaceutical Company Limited Novel imidazole derivatives, production method thereof and use thereof
AU2002214320A1 (en) 2000-11-20 2002-05-27 Takeda Chemical Industries Ltd. Imidazole derivatives, process for their preparation and their use
ATE440096T1 (de) 2000-12-08 2009-09-15 Takeda Pharmaceutical Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
CA2519211A1 (en) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited Release control compositions
WO2008021250A2 (en) * 2006-08-10 2008-02-21 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
UA105794C2 (uk) 2009-06-26 2014-06-25 Новартіс Аг 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17
WO2011041737A2 (en) 2009-10-02 2011-04-07 Fred Hutchinson Cancer Research Center Gain-of-function bcl-2 inhibitors
WO2011041731A2 (en) 2009-10-02 2011-04-07 Fred Hutchinson Cancer Research Center Method of inhibiting bcl-2-related survival proteins
EP2600855A2 (en) 2010-08-04 2013-06-12 Pellficure Pharmaceuticals, Inc. Combination therapy for the treatment of prostate carcinoma
EP2627648A1 (en) 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
EA201390876A1 (ru) * 2010-12-13 2013-12-30 Вайамет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
MX359399B (es) 2011-04-28 2018-09-27 Novartis Ag Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
JP5990059B2 (ja) * 2012-08-03 2016-09-07 花王株式会社 StAR発現抑制剤
JP6275378B2 (ja) * 2012-12-26 2018-02-07 エヌ・イーケムキャット株式会社 カルバゾール類の製造方法およびこの方法により製造されたカルバゾール類。
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
CA2960750A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
AU2017350690A1 (en) 2016-10-24 2019-06-13 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
CN109748884B (zh) * 2019-02-19 2022-06-24 成都恒昊创新科技有限公司 一种铁死亡抑制剂及其制备方法与应用
EP3786156A4 (en) 2018-04-27 2022-02-23 Chengdu Henghao Investment Co. Limited 10H-PHENOTHIAZINE FERROPTOSE INHIBITOR AND METHOD OF PRODUCTION THEREOF AND USE THEREOF
US20230021442A1 (en) * 2019-11-21 2023-01-26 Chengdu Henghao Innovative Science And Technology Co., Ltd. Phenothiazine ferroptosis inhibitor, preparation method therefor and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
DE3942227A1 (de) * 1989-12-21 1991-06-27 Bayer Ag Triarylmethan-farbbildner
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
WO1995004723A1 (fr) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive

Also Published As

Publication number Publication date
EP0721943A4 (en) 1996-09-04
HUT75871A (en) 1997-05-28
EP0721943A1 (en) 1996-07-17
CN1131944A (zh) 1996-09-25
US5807880A (en) 1998-09-15
HU9600813D0 (en) 1996-05-28
CA2170874A1 (en) 1995-04-06
NZ273681A (en) 1996-09-25
PL313769A1 (en) 1996-07-22
AU7707194A (en) 1995-04-18
FI961418A0 (fi) 1996-03-29
WO1995009157A1 (fr) 1995-04-06
NO961274L (no) 1996-03-29
FI961418A (fi) 1996-03-29
KR960704852A (ko) 1996-10-09
AU679119B2 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
NO961274D0 (no) Azolderivat og farmasöytiske preparat derav
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO2009028I1 (no) Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat
NO943511D0 (no) Farmasöytiske preparater og anvendelse derav
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
NO922506D0 (no) Farmasoeytiske preparat
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
BR1100329A (pt) Composto e formulação farmacêutica
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NO924768D0 (no) Farmasoeytisk preparat og fremgangsmaate for dets fremstilling
NO954146D0 (no) Belagte farmasöytiske preparater
NO984107L (no) Kappa-agonist-forbindelser og farmas°ytiske preparater derav
NO943888D0 (no) Farmasöytisk preparat
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
NO934372D0 (no) Nye forbindelser og farmas!ytisk preparat derav
NO960722D0 (no) Benzazepinderivat, farmasöytisk preparat inneholdende dette, og mellomprodukter for dette
NO180678C (no) N-substituerte heterocykliske forbindelser og farmasöytisk preparat
NO981241D0 (no) Heteroarylsubstituerte akryloylguanidinderivater og farmasöytiske preparater inneholdende disse
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO973980D0 (no) Imiadazolderivater og medisinsk preparat
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
NO972023D0 (no) Benzisoksasolderivater og pesticidpreparater inneholdende disse
NO304985B1 (no) Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og farmas°ytisk formulering